<DOC>
	<DOCNO>NCT03091894</DOCNO>
	<brief_summary>study effect add dexmedetomidine intravenous infusion propofol intravenous infusion sedation drug induce sleep endoscopy</brief_summary>
	<brief_title>Dexmedetomidine Added Propofol Drug Induced Sleep Endoscopy</brief_title>
	<detailed_description>In current study 50 adult patient obstructive sleep apnea randomly allocate one two group . Propofol group ( 25 patient ) receive propofol infusion.Propofol-dex . group ( 25 patient ) receive dexmedetomidine intravenous infusion addition propofol infusion . success sedation drug induce sleep endoscopy primary outcome . The secondary outcome sedation level evaluate Modified observer 's assessment alertness sedation ( OAA/S ) score , time sufficient sedation , total endoscopy time , incidence oxygen desaturation adverse haemodynamic effect .</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>age 18 year patient obstructive sleep apnea ASA 1and2 patient refusal age le 18 year morbid obesity know suspect allergy study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>dexmedetomidine , propofol , sleep endoscopy , sedation</keyword>
</DOC>